, Singapore

Eu Yan Sang’s net profit slipped 38% to $5.45m in Q3

Due to higher expenses.

Locally-listed traditional Chinese medicine manufacturer Eu Yan Sang reported that its net profit declined 38% year-on-year to $5.45m in the third quarter.

The decline was attributed to lower gross margin contribution and increased operating expenses. Gross margin for the quarter under review dipped 2.6% due mainly to the impact of sales mix and longer lead time to Chinese New Year. 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!